PATTERNS OF PROGRESSION IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER WHO UNDERWENT RADICAL CYSTECTOMY AFTER INTRAVESICAL BCG FAILURE

被引：0
|
作者：
Gaya, J. M. [1 ]
Huguet, J. [1 ]
Palou, J. [1 ]
Rodriguez Faba, O. [1 ]
Algaba, F. [1 ]
Villavicencio, H. [1 ]
机构：
[1] Fundacio Puigvert, Dept Urol, Barcelona, Spain
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2009年 / 8卷 / 04期
关键词：
D O I：
10.1016/S1569-9056(09)60655-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [41] The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis
    Packiam, Vignesh T.
    Labbate, Craig, V
    Boorjian, Stephen A.
    Tarrell, Robert
    Cheville, John C.
    Avulova, Svetlana
    Sharma, Vidit
    Tsivian, Matvey
    Adamic, Brittany
    Mahmoud, Mohammad
    Werntz, Ryan P.
    Smith, Norm D.
    Karnes, R. Jeffrey
    Tollefson, Matthew K.
    Steinberg, Gary D.
    Frank, Igor
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (07) : 436.e1 - 436.e8
  • [42] A genome-wide association study on intravesical recurrence after BCG therapy for non-muscle invasive bladder cancer
    Nagakawa, Shohei
    Shiota, Masaki
    Fujimoto, Naohiro
    Yamamoto, Yoshiaki
    Tsukahara, Shigehiro
    Matsumoto, Takashi
    Kashiwagi, Eiji
    Takeuchi, Ario
    Inokuchi, Junichi
    Uchiumi, Takeshi
    Matsuyama, Hideyasu
    Eto, Masatoshi
    CANCER SCIENCE, 2022, 113 : 1588 - 1588
  • [43] Neoadjuvant Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer
    Messing, Edward M.
    BLADDER CANCER, 2023, 9 (02) : 191 - 192
  • [44] Salvage Hyperthermic Gemcitabine and Docetaxel Combination Chemotherapy After BCG Failure in Non-Muscle Invasive Bladder Cancer Patients
    Rao, Mounica Y.
    Kang, Paul
    Tarajkowski, Jamaka C.
    Mobley, Debra L.
    Lamm, Donald L.
    BLADDER CANCER, 2020, 6 (01) : 25 - 32
  • [45] OUTCOME OF UPFRONT RADICAL CYSTECTOMY AND ORTHOTOPIC BLADDER IN PATIENTS WITH HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER.
    Salam, Muhammad Abdus
    Haque, Mir Ehteshamul
    Islam, Faisal
    Ibrahim, Kaiser
    Islam, Shahinul
    Rahman, Shafiqur
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1121 - E1122
  • [46] Sequential intravesical gemcitabine and docetaxel in the treatment of BCG-naive patients with non-muscle invasive bladder cancer.
    Thomas, Lewis
    Steinberg, Ryan
    Nepple, Kenneth Gerard
    O'Donnell, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [47] THE OUTCOME OF THE INTRAVESICAL BCG TREATMENT IN NAIVE POSITIVE TUBERCULIN SKIN TEST NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS
    Shusit, P.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 285 - 285
  • [48] Patterns of use of BCG maintenance therapy for non-muscle invasive bladder cancer in Australia
    Roberts, J.
    Meyer, J-P.
    BJU INTERNATIONAL, 2015, 115 : 103 - 104
  • [49] Can presence of granuloma act as a marker of response to intravesical BCG in non-muscle invasive bladder cancer?
    Jallad, S.
    Hughes, P.
    Gupta, A.
    Goubet, S.
    Symes, A.
    Larner, T.
    Thomas, P.
    BJU INTERNATIONAL, 2012, 109 : 36 - 36
  • [50] Intravesical BCG instillation for non-muscle invasive bladder cancer: Prevalence of adverse effects & association with efficacy
    Udovicich, C.
    Nankivell, P.
    Barberi, A.
    Page, D.
    Jenkins, M.
    Goad, J.
    Clarke, A.
    Niall, O.
    Temelcos, C.
    Cleeve, L.
    Wong, L-M.
    BJU INTERNATIONAL, 2015, 115 : 106 - 107
12345